Literature DB >> 3924719

Effect of misoprostol and cimetidine on gastric cell labeling index.

A Fich, N Arber, M Sestieri, G Zajicek, D Rachmilewitz.   

Abstract

The effect of misoprostol and cimetidine on gastric cell turnover was studied. Endoscopic biopsy specimens of fundic and antral mucosa were obtained from duodenal ulcer patients before and after 4 wk of therapy with cimetidine 1.2 g/day or misoprostol 800 micrograms/day. Biopsy specimens were incubated with [3H]thymidine. Glandular column length and number of labeled cells were determined after autoradiography. There was no significant difference in column length of antral or fundic glands before or after therapy with cimetidine and misoprostol. The number of antral and fundic labeled cells was significantly decreased after misoprostol treatment (3.6 +/- 0.3 and 4.6 +/- 0.4, mean +/- SE), as opposed to their respective number before therapy (6.9 +/- 0.5 and 8.3 +/- 0.8) (p less than 0.01). On the other hand, after treatment with cimetidine, the number of antral and fundic labeled cells was significantly higher (11.8 +/- 0.9 and 7.5 +/- 1.0, respectively) as compared with their number before therapy (5.7 +/- 0.5 and 5.6 +/- 0.6, respectively). The decreased gastric cell turnover induced by misoprostol indicates that the trophic effect of prostanoids on gastric mucosa is not due to an increase in cellular kinetics. The increased gastric cell turnover induced by cimetidine may contribute to its therapeutic effect in peptic ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924719     DOI: 10.1016/0016-5085(85)90745-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

Review 1.  Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.

Authors:  J G Penston; K G Wormsley
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

2.  Peptic ulcer disease. Pathophysiology and current medical management.

Authors:  B F Scharschmidt
Journal:  West J Med       Date:  1987-06

3.  Effect of prostaglandins on the adult rat stomach and intestine.

Authors:  F Halter; A Baumgartner; H R Koelz; W H Reinhart
Journal:  Gut       Date:  1987       Impact factor: 23.059

Review 4.  Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.

Authors:  J P Monk; S P Clissold
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

5.  Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine.

Authors:  M B Kimmey; F E Silverstein; D R Saunders; R C Chapman
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

6.  Stimulation of glycoprotein and protein synthesis in isolated pig gastric mucosal cells by prostaglandins.

Authors:  H K Heim; A Oestmann; K F Sewing
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

7.  Effect of chronic misoprostol ingestion on rat gastric morphology and cell turnover.

Authors:  A Fich; N Arber; E Okon; G Zajicek; D Rachmilewitz
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

8.  Prostaglandins and the gastric epithelium: effects of misoprostol on gastric epithelial cell proliferation in the dog.

Authors:  R A Goodlad; A J Madgwick; M R Moffatt; S Levin; J L Allen; N A Wright
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

9.  Effect of misoprostol and cimetidine on gastric cell turnover.

Authors:  A Fich; N Arber; M Sestieri; G Zajicek; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.